Dicoumarol suppresses intrahepatic cholangiocarcinoma growth via modulation of the PI3K/Akt signaling pathway
Biochemical and Biophysical Research Communications · 2026-11 · 839 · 154686
DOI: 10.1016/j.bbrc.2026.154686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-11. Verfasst von Zeyuan Qiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy, West China Hospital…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Proto-Oncogene Proteins c-akt, Signal Transduction, Phosphatidylinositol 3-Kinases. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Sichuan University, West China Hospital, Sichuan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver malignancy after hepatocellular carcinoma (HCC), characterized by high invasiveness and poor clinical prognosis. Dicoumarol (Dic) is a naturally occurring coumarin compound that was previously used clinically as an anticoagulant. In recent years, increasing attention has been given to its potential antitumor effects. This study aimed to investigate the antitumor effect of the natural compound Dic in ICC and its underlying molecular mechanisms. Our results demonstrated that Dic significantly inhibited the proliferation, migration, and invasion of ICC cells in vitro while promoting apoptosis. In vivo, Dic markedly reduced tumor burden in a murine ICC model without causing obvious hepatotoxicity, suggesting acceptable tolerability under the therapeutic dosing regimen used in this study. RNA-seq identified a total of 1374 differentially expressed genes (DEGs) following Dic treatment, and KEGG pathway analysis revealed alterations in multiple cancer-related pathways, including PI3K/Akt signaling. Western blot analysis further confirmed that Dic significantly inhibited Akt phosphorylation in both ICC cells and tumor tissues, corroborating the suppression of PI3K/Akt signaling by Dic. This study provides new experimental evidence for the potential of Dic in the treatment of ICC and supports further investigation of Dic as a potential therapeutic candidate for ICC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
- Hepatobiliary and Pancreatic Surgery, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. Electronic address: qiuguoteng@163.com.
- Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China. Electronic address: haichuanwang…
Förderung
- Sichuan University
- West China Hospital, Sichuan University
- National Natural Science Foundation of China
- Sichuan Provincial Science and Technology Support Program
- China Postdoctoral Science Foundation
Zitieren
APA
Qiang, Z., Qin, K., Zhou, Y., Huang, T., Zhang, H., Tong, Y., Pan, H., Zeng, Y., Qiu, G., & Wang, H. (2026). Dicoumarol suppresses intrahepatic cholangiocarcinoma growth via modulation of the PI3K/Akt signaling pathway. Biochemical and Biophysical Research Communications, 839, 154686. https://doi.org/10.1016/j.bbrc.2026.154686
Vancouver
Qiang Z, Qin K, Zhou Y, Huang T, Zhang H, Tong Y, et al. Dicoumarol suppresses intrahepatic cholangiocarcinoma growth via modulation of the PI3K/Akt signaling pathway. Biochemical and Biophysical Research Communications. 2026;839:154686. doi:10.1016/j.bbrc.2026.154686
BibTeX
@article{Qiang2026,
author = {Qiang, Zeyuan and Qin, Ke and Zhou, Yuanzhi and Huang, Tengda and Zhang, Hongchen and Tong, Yi and Pan, Hongyuan and Zeng, Yong and Qiu, Guoteng and Wang, Haichuan},
title = {Dicoumarol suppresses intrahepatic cholangiocarcinoma growth via modulation of the PI3K/Akt signaling pathway},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
volume = {839},
pages = {154686},
doi = {10.1016/j.bbrc.2026.154686}
}
EUVIMED